新加坡：国家抗菌药物耐药性监测和评估框架战略行动计划（2025-2030年）

TheNSAPv2 Monitoring and Evaluation Frameworkwas developed by theOne HealthAMR Workgroup (OH AMRWG)and is jointlypublishedby: •Communicable DiseasesAgency (CDA)•National Environment Agency (NEA)•National Parks Board (NParks)•PUB, Singapore’s National Water Agency (PUB) Forenquiries,pleasecontactthe Secretariat at:Antimicrobial Resistance Coordinating Office, CDA, Singapore National Strategic Action Plan on Antimicrobial Resistance (version 2.0)-Monitoring & Date of publication:12 November2025 ONE HEALTH AGENCIES: TABLE OF CONTENTS INTRODUCTION...............................................................................................................................2LOGIC MODEL..................................................................................................................................3SECTION I: MONITORING THE NATIONAL STRATEGIC ACTION PLAN ON AMR..............4SECTION II. EVALUATION..............................................................................................................8 INTRODUCTION Singapore’s second National Strategic Action Plan on AMR (NSAPv2)envisions“ASingapore where AMR iseffectively controlled”, with themission “To prevent theemergence and spread of drug-resistant organisms, and preserve the effectiveness of Thisdocument sets outthe first iteration of aframework for monitoringand evaluating(M&E)the NSAPv2.The M&EFrameworkis designed tomeasure effectiveness of the NSAP infulfilling its missionandtrackprogress ofitsimplementation under the five Core Strategies. The NSAPv2M&E frameworkcomprises two parts: I.TheMonitoring component (Part I)encompasses two forms of monitoring: a.Monitoring of the process and outputs-This focuses on the NSAP’s inputs,activitiesand outputs,and is designed to monitor the progress of its b.Monitoring and evaluation of outcomes-This focuses on the NSAP’s goals andtargets, and isdesigned to assess the effectiveness of NSAP towards achieving Part Idescribes (i) the criteriaforselection of targets and indicators, (ii) the targetsand indicators selected for monitoring, (iii) how the activities of the Core Strategies Technical Reference Sheets for Targets and Indicators are found inAnnex AandAnnex Brespectively.Annex Cdescribes the process involved in developing the II. TheEvaluation component (PartII)describeshowoutcomes, impact and overall Theintendedaudience for this framework includesthe One Health AMR Workgroup (OHAMRWG; as thenational multisectoral committee), the AMR Coordinating Office (AMRCO;as thenational AMR secretariat),agencies in the respectivesectors implementing AMR The NSAP M&E Framework will remain dynamic and be reviewed periodically to ensurerelevance.As the global AMR situation evolves,so will Singapore’s response.Newknowledge on AMR and measures to contain it will continue to emerge. Singapore will alsobuild on past experience and new evidence to advance our national strategy against AMR. LOGICMODEL SECTIONI: MONITORINGTHENATIONAL STRATEGIC ACTION PLAN ONAMR 1.M&ETerminology The following definitionsapply in this Framework: •Goals:Long-term objectives and the desired outcomeor results of each CoreStrategy.•Targets:Specific, concrete and measurable benchmarks or outcomes that are to be 2.Goals 3.Targets TheNSAPv2 sets outeighttargets to achieve by 2030,withthe following criteria: •Specific: Clear and specific on thedesired outcome.•Measurable:Measured by specific indicators.•Ambitious+Achievable: Able to drive concrete action while avoiding low-hanging fruits. •Relevant: The target must be relevant tothe nationalcontext.•Timebound:By 2030.•One Health: Targets are distributed across all sectors. Table2lists thetargetsto be achieved by2030, mapped to the13goals of the NSAPv2 CoreStrategies.Further descriptionsof the targets are foundinAnnex A. 4.M&E indicators The NSAPv2M&EIndicatorsmeasureprogresstowards the Missionandfacilitate mission andgoals of the NSAPv2.Table 2 lists the indicators formonitoring from2025to2030, with full technical descriptions and definitions found inAnnexB.OtherM&Eindicators Indicators were selected based on the following criteria: •Specific:The indicatorcan be clearly defined withno ambiguousterms.•Measurable:The indicator must have identifiable sources of data, or themethodstocollect the data can be established.•Relevant:The indicator must be relevant to theMission of the NSAP. Research and Evidence B10. Number of AMR research projects involving two or more sectors. B11.Proportion (%) of target population vaccinated against (i)influenza and(ii)Streptococcus pneumoniae. 5.Data collection and reporting Quantitative data on indicators will be collected by AMRCO on an annual basis and reportedon the appropriate platform. This could include the One Health Report on AMR and AMU,the NSAP progress report, website, dashboardor other platforms designed for this purpose. 6.Data management AMRCO as Secretariatfor theOH AMRWGservesas custodian of M&E datacollect